Complement C4b
-
Subject Areas on Research
- Annihilating host defense.
- Banff 2011 Meeting report: new concepts in antibody-mediated rejection.
- Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
- C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
- Cleavage of membrane-bound C3b and C3bi by viable human neutrophils (PMN).
- Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.
- Inhibition of the complement cascade by the major secretory protein of vaccinia virus.
- Regulation of complement activity by vaccinia virus complement-control protein.
- Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
- Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
- The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction.